Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
You have to stop use and seek medical advice if unusual symptoms occur
doi:10.2146/ajhp120291 3Strom BL, Schinnar R, Apter AJ, et al
under the brand name Scenesse, an implantable form of afamelanotide has been approved in the EU, US, and elsewhere to reduce phototoxicity in erythropoietic protoporphyria (EPP)
Tracking your injection site rotation is especially helpful to avoid skin irritation from using the same spot too often
US$ 26.42
US$ 21.63
US$ 25.06
US$ 25.94
US$ 27.61
US$ 26.01
